Related by context. All words. (Click for frequent words.) 82 dirucotide 73 dirucotide MBP# 72 MBP# dirucotide 69 JAK inhibitor 68 Archexin 67 bardoxolone 67 Plicera 67 Phase IIb trials 66 phase IIb clinical 66 Bicifadine 66 OvaRex ® MAb 66 HuMax CD4 66 Phase IIb clinical trials 66 phase IIb trial 66 AZILECT R 66 Phase Ib 66 forodesine 66 otelixizumab 65 Icatibant 65 lomitapide 65 TELINTRA 65 Fodosine 65 elotuzumab 65 Alzhemed TM 65 Traficet EN 65 Panzem R 65 AZILECT ® 65 #D#C# 65 Amrubicin 65 Corlux 65 synthetic retinoid 65 Allovectin 7 R 65 Azedra 65 KNS # 64 teriflunomide 64 Bezielle 64 AEG# 64 tivozanib 64 registrational trial 64 HQK 64 Phase 2b study 64 Phase Ib study 64 INCB# [001] 64 Zerenex 64 pradefovir 64 oral ridaforolimus 64 Dacogen injection 64 Phase III clinical trials 64 SNT MC# 64 RhuDex ® 64 CTAP# Capsules 64 Phase 2a trial 64 Pimavanserin 64 PREOS 64 UPLYSO 64 IMA# 64 Civacir 64 Xanafide 63 TBC# 63 Phase Ib clinical 63 CRD5 63 generation purine nucleoside 63 EndoTAG TM -1 63 OncoVEX GM CSF 63 Mipomersen 63 antibody MAb 63 TACI Ig 63 AGILECT R 63 PREOS R 63 canakinumab 63 HspE7 63 ATL# [001] 63 HGS# 63 Altastaph 63 phase IIa 63 LEP ETU 63 PXD# 63 AeroLEF TM 63 TOCOSOL Paclitaxel 63 atacicept 63 Neuradiab 63 phase IIb 63 ATL/TV# 63 FOLOTYN ® 63 eniluracil 63 voreloxin 63 Allovectin 7 63 registrational 63 INT# [002] 63 Phase IIa trial 63 ONCONASE R 63 Onco TCS 63 VAPRISOL 63 BAY #-# 63 GED aPC 62 Diamyd ® 62 NEBIDO 62 Fibrillex TM 62 YONDELIS 62 CIMZIA TM 62 GALNS 62 Asentar 62 CBLC# 62 Perifosine 62 Zelrix 62 liprotamase 62 Phenoptin 62 XmAb# 62 PEGylated interferon 62 Phase IIa trials 62 Phase III clinical 62 Flutiform TM 62 reslizumab 62 Phase #b/#a 62 MEK inhibitor 62 ADAGIO study 62 Fx #A 62 PEGylated interferon beta 1a 62 Azilect ® 62 Phase 2b clinical trials 62 Vilazodone 62 IRX 2 62 CoFactor 62 MEK inhibitor RDEA# 62 ularitide 62 Allovectin 7 ® 62 vidofludimus 62 Octreotide 62 immunomodulatory therapy 62 Symadex 62 Aviptadil 62 MNTX 62 confirmatory Phase III 62 ELND# 62 Amigal 62 rFIXFc 62 EFAPROXYN 62 lumiliximab 62 Fampridine SR 62 Hepatocellular Carcinoma HCC 62 LAF# 62 lucinactant 62 NP2 Enkephalin 62 Ozarelix 62 EVIZON TM 62 Viramidine 62 phase IIa clinical 62 tolevamer 62 Aerosurf 62 NVA# 62 Phase 2a clinical trials 62 vilazodone 62 Lupuzor 62 SILENOR TM 62 ruxolitinib 62 Rescula 62 renin inhibitor 62 rFVIIIFc 62 teduglutide 62 Alemtuzumab 62 Phase IIIb clinical 62 CB2 selective receptor agonist 62 relapsing multiple sclerosis 62 mipomersen 62 Cetrorelix 62 EDEMA3 62 Phase 1b trial 62 diarrhea predominant irritable 62 Surfaxin LS 62 Teriflunomide 62 LymphoStat B TM 62 Onconase 62 R#/MEM # 62 vosaroxin 62 Phase III trials 62 OvaRex R 62 ozarelix 62 OHR/AVR# 62 octreotide implant 62 CDP# 62 GAMMAGARD 62 drug ISA# 61 TRO# 61 LEVADEX ™ 61 nonclinical studies 61 Ambrisentan 61 Phase IIb trial 61 PHX# 61 ProSavin 61 nitazoxanide 61 Aflibercept 61 Nuvion 61 PLK1 SNALP 61 diabetic neuropathic pain 61 IND submission 61 CR# vcMMAE 61 Pazopanib 61 Phase 2a clinical 61 visilizumab 61 OncoGel 61 candidate Zenvia 61 Phase IIb clinical 61 Genz # 61 oral prodrug 61 Maribavir 61 Alpharadin 61 TYZEKA 61 Cethrin 61 Catena ® 61 ACTEMRA TM 61 HuMax EGFr 61 Orazol 61 personalized immunotherapy 61 CytoFab 61 ONTAK 61 SILENOR 61 valopicitabine 61 NDA resubmission 61 cannabinor 61 lupus nephritis 61 Panzem R NCD 61 ALN PCS 61 Phase 2b trial 61 TREDAPTIVE 61 Tamibarotene 61 HuMax CD# 61 cinacalcet HCl 61 torezolid phosphate 61 Triolex 61 IMiDs 61 Evoltra TM 61 oral methylnaltrexone 61 DAVANAT R 61 elacytarabine 61 Factor VIIa 61 SEBIVO 61 alemtuzumab Campath 61 liposomal formulation 61 GSK# [002] 61 Dalbavancin 61 Loramyc R 61 tezampanel NGX# 61 DAVANAT ® 61 Neurodex 61 sumatriptan DosePro 61 Laquinimod 61 alvespimycin 61 ulimorelin 61 Phase Ia 61 ASONEP 61 AA amyloidosis 61 Onalta 61 Phase 1b 61 Canvaxin 61 CCX# 61 Acetavance 61 baminercept 61 Q#IR 61 VEGF Trap 61 Actimmune ® 61 Plenaxis TM 61 targeted radiotherapeutic 61 SHPT 61 Annamycin 61 Anavex #-# 61 Sebivo 61 RSD# oral 61 Glypromate 61 DXL# 61 Dacogen decitabine 61 ISIS # 61 PROMACTA 61 PRT# 61 MAA submission 61 eprotirome 60 methylnaltrexone 60 DDP# 60 AQ4N 60 danoprevir 60 davunetide 60 Marqibo 60 BioMS Medical 60 docetaxel Taxotere ® 60 CEQ# 60 brivaracetam 60 Cimzia TM 60 HCV protease inhibitors 60 Stimuvax R 60 Campath ® 60 Certolizumab pegol 60 non nucleoside HCV 60 Telaprevir 60 Golimumab 60 Safinamide 60 Zenvia ™ 60 tasocitinib 60 Phase IIB 60 ANAVEX #-# [003] 60 interferon beta 1b 60 Amplimexon 60 Dasatinib 60 candidate deforolimus 60 ARIKACE 60 eculizumab 60 BrachySil TM 60 amrubicin 60 LymphoStat B 60 HCD# [002] 60 mertansine 60 velafermin 60 CCR9 antagonist 60 ISTODAX 60 Trizytek 60 Aurexis 60 Mitoxantrone 60 daclizumab 60 CRMD# 60 HepeX B 60 clinical pharmacology studies 60 midstage trials 60 ARIKACE ™ 60 BLA filing 60 investigational humanized monoclonal antibody 60 Relovair 60 voclosporin 60 rilonacept 60 indibulin 60 pharmacological chaperone 60 corticosteroid dexamethasone 60 custirsen 60 epothilone 60 thymalfasin 60 sodium Injection 60 HuLuc# 60 compound INCB# 60 Cloretazine 60 Oracea TM 60 PEG SN# 60 Soliris TM eculizumab 60 NGX# 60 Revimmune 60 Enzyme Replacement Therapy 60 IAP inhibitors 60 oral calcitonin 60 INCB# [002] 60 refractory gout 60 oxymorphone ER 60 MGCD# [001] 60 LymphoStat B belimumab 60 Phase IIa clinical 60 Pradefovir 60 CCR5 antagonist 60 ONSOLIS 60 MyVax R 60 Locteron 60 squalamine 60 PDE4 inhibitor 60 DR Cysteamine 60 Firazyr 60 Daclizumab 60 MyVax ® 60 AVONEX ® 60 Prednisporin TM 60 L BLP# 60 nalbuphine ER 60 PEG Interferon lambda 60 phase IIb III 60 GLP toxicology studies 60 XL# XL# XL# XL# 60 Urocidin 60 RG# [001] 60 6R BH4 60 investigational compound 60 afamelanotide 60 SPRYCEL ® 60 Revlimid lenalidomide 60 Clonicel 60 BENLYSTA ® 60 talactoferrin 60 Tyrima 60 ThGRF 60 pseudobulbar affect PBA 60 satraplatin 60 Ocrelizumab 60 Proxinium TM 60 Alvesco R 60 Elagolix 60 RhuDex 60 mGluR5 NAM 60 PEG PAL 60 Marqibo TM 60 SARMs 60 Omacetaxine 60 sorafenib tablets 60 prGCD 60 TELCYTA 60 Vernakalant 60 pafuramidine 60 clinical trials 60 carfilzomib 60 KRN# 60 Interferon alpha 60 CD# CEA 60 Firazyr ® 60 albinterferon alfa 2b 60 MAXY alpha 60 eltrombopag 60 SinuNase TM 60 Santhera 60 selective androgen receptor modulator 60 Sym# 60 Liprostin 60 Azedra TM 60 ocrelizumab 60 Ophena TM 60 riociguat 60 lixivaptan 60 RenaZorb TM 60 cilengitide 60 FOLOTYN 60 glucokinase activator 60 RSD# 60 schizophrenia CIAS 60 Locteron ® 60 FTY# 60 Dapagliflozin 60 Pennsaid R 60 Multikine 60 ospemifene 60 Velcade bortezomib 60 TYKERB 60 oxypurinol 60 RRMS patients 60 docetaxel Taxotere R 60 Fabry Disease 60 elagolix 60 Clavis Pharma 60 DAVANAT 60 TLK# 59 ambrisentan 59 pivotal Phase III 59 StaphVAX 59 MAGE A3 ASCI 59 tramiprosate ALZHEMED TM 59 Kuvan 59 Sulonex TM 59 vismodegib 59 Phase #b/#a trial 59 Kamada AAT 59 Tanespimycin 59 Behcet uveitis 59 Genasense ® oblimersen 59 APEX PD 59 alvimopan 59 ponatinib 59 xanthine oxidase inhibitor 59 Syncria 59 CAMPATH 59 APF# 59 GSK# [001] 59 E1 INT TM 59 SUTENT ® 59 bevasiranib 59 Atiprimod 59 PS# [001] 59 Troxatyl 59 Tavocept 59 phase Ib 59 tecarfarin 59 regorafenib 59 cystinosis patients 59 BrachySil 59 ancrod 59 ANTEGREN 59 LE DT 59 DEB# 59 Aurora kinase inhibitor 59 Virulizin R 59 KIACTA ™ 59 EVIZON 59 ALN RSV# 59 Riquent 59 PRX # 59 Octreolin 59 MAXY VII 59 confirmatory Phase 3 59 zileuton 59 Iluvien ® 59 AVN# [001] 59 acetonide FA 59 blinatumomab 59 dose cohort 59 Zelapar 59 SUCCEED trial 59 Serdaxin 59 OFIRMEV 59 Cethromycin 59 Phase Ib II 59 CYCLOSET 59 FAMPYRA 59 CTA# 59 Vectibix panitumumab 59 MEK inhibitors 59 Puricase 59 oral RSD# 59 Exherin TM 59 rindopepimut 59 BCX# 59 MabCampath 59 Phase IIa clinical trials 59 Aganocide 59 deforolimus 59 Lixivaptan 59 maximally tolerated dose 59 Frova ® 59 Raptiva ® 59 Preotact 59 RELOVAIR ™ 59 Squalamine 59 tiapamil 59 Spiegelmer ® 59 Nexavar ® 59 volociximab 59 urocortin 2 59 intravenous formulation 59 MAXY G# 59 IV APAP 59 Tezampanel 59 NDA submission 59 dosing cohort 59 obatoclax 59 Viprinex 59 siRNA therapeutics 59 IND enabling 59 HCV protease inhibitor 59 celgosivir 59 huC# DM4 59 Cloretazine R VNP#M 59 Phase 1b clinical 59 Vidofludimus 59 Viprinex TM 59 romiplostim 59 TRIOLEX 59 sitaxsentan 59 PRTX 59 Onalta ™ 59 dimebon 59 Rasagiline 59 LY# [003] 59 Tarvacin TM 59 HGS ETR1 59 tezampanel 59 Ophena 59 ACV1 59 ZADAXIN ® 59 Cerashield 59 SEPET TM 59 Phase 2b 59 therapeutic monoclonal antibody 59 alagebrium 59 DPX Survivac 59 BEMA TM Fentanyl 59 forodesine hydrochloride 59 ALTU 59 Carfilzomib 59 MIRCERA 59 Tasimelteon 59 R#/MEM 59 CYT# potent vascular disrupting 59 enzastaurin 59 prostone 59 preclinical studies 59 CORT # 59 Diamyd R 59 Oncaspar 59 IAP inhibitor 59 tafamidis 59 Bronchitol 59 Phase Ib IIa 59 ataluren 59 EndoTAG TM 59 Chemophase 59 phase IIb study 59 EOquin TM 59 ACZ# 59 SILENOR ™ 59 Telbivudine 59 PEG INTRON 59 pitavastatin 59 Evoltra 59 ALN TTR# 59 ALVESCO HFA 59 Tracleer r 59 ZK EPO 59 rasagiline tablets 59 Insegia 59 Pirfenidone 59 BLA submission 59 Phase #b/#a clinical 59 incyclinide 59 Phase III Clinical Trials 59 Navelbine ® 59 Duromist ™ 59 Avanafil 59 Hematide ™ 59 SRT# [003] 59 Phase 2b clinical 59 NeuroSTAT ® 59 isoform selective 59 pediatric malignancies 59 ATryn ® 59 successfully commercialize Iluvien 59 Myocet 59 Topical Interferon Alpha 2b 59 COPAXONE ® 59 acyclovir Lauriad R 59 Phase 1b clinical trials 59 Ofatumumab 59 refractory acute myeloid 59 Torisel 59 preclinical 59 BAL# [002] 59 LEUKINE 59 receptor tyrosine kinase inhibitor 59 Soliris eculizumab 59 Cintredekin Besudotox 59 drug GAP #B# 59 TPI ASM8 58 rALLy clinical trial 58 Glatiramer Acetate 58 Relivar 58 relapsing remitting multiple sclerosis 58 Azixa 58 Phase IIa 58 metaglidasen 58 ZOLINZA 58 SinuNase 58 indiplon capsules 58 tetrabenazine 58 Egrifta 58 Zavesca ® 58 Bioral Amphotericin B 58 Mpex 58 Cethrin R 58 Onsolis 58 Kepivance 58 Aryplase 58 oral gallium 58 URG# 58 Panitumumab 58 aplindore 58 Glufosfamide 58 Targeted Chemotherapy 58 GLPG# 58 investigational monoclonal antibody 58 mGluR5 negative 58 Voraxaze 58 Nanobody 58 RECOTHROM R 58 Natalizumab 58 subcutaneous formulation 58 proteasome inhibitor 58 dacetuzumab 58 romazarit 58 pegloticase 58 Boceprevir 58 Diabetic Macular Edema 58 Indaflex TM 58 Ceflatonin 58 PD LID 58 Phase IIb 58 apricitabine ATC 58 aerosolized KL4 surfactant 58 perifosine 58 TriRima 58 GAMMAGARD LIQUID 58 ApoB SNALP 58 post herpetic neuralgia PHN 58 Arimoclomol 58 ICA # 58 Arcalyst 58 triphendiol 58 Campath alemtuzumab 58 systemically administered 58 MAP# 58 Fibrillex 58 panitumumab Vectibix 58 Arikace 58 fipamezole 58 Tesetaxel 58 ThermoDox ® 58 mGluR2 NAM 58 novel oral anticoagulant 58 velaglucerase alfa 58 Bortezomib 58 XL# XL# 58 anticancer agent 58 Zemplar Capsules 58 budesonide foam 58 Actemra tocilizumab 58 Clofarabine 58 OMAPRO 58 anticancer compound 58 regadenoson 58 neratinib 58 Reverset 58 Aegera 58 TREANDA 58 Simulect 58 Omigard 58 ELACYT 58 Cleviprex TM clevidipine 58 tocilizumab 58 angiogenesis inhibitor 58 TMC# [002] 58 Phase #/#a 58 BNC# 58 Exalgo 58 tanespimycin 58 CD# monoclonal antibody 58 Anidulafungin 58 Cinquil 58 interferon gamma 1b 58 CIMZIA ™ 58 postoperative ileus 58 faropenem medoxomil 58 vascular disrupting agent 58 axitinib 58 Survivin antagonist 58 Virulizin 58 EGS# 58 PSN# [002] 58 Memryte 58 omacetaxine mepesuccinate 58 oral rivaroxaban 58 RAPAFLO 58 RE SURGE 58 oral formulation 58 Guanilib 58 Nanobody ® 58 preclinically 58 Personalized Immunotherapy 58 Intravenous CP 58 bicifadine 58 compound PMX # 58 AERx iDMS 58 MYDICAR ® 58 intranasal formulation 58 DOS# 58 Chrysalin 58 TRANSDUR Sufentanil 58 XL# anticancer compounds 58 PRX# 58 Androxal TM 58 LHRH antagonists 58 BCR ABL inhibitors 58 MKC# MKC# PP 58 Prodarsan ® 58 Technosphere Insulin 58 R sorafenib tablets 58 inhaled formulation 58 non metastatic osteosarcoma 58 Fidaxomicin 58 Phase III 58 FIRAZYR 58 NeuVax 58 Factor Xa inhibitor 58 Friedreich Ataxia FRDA 58 dexanabinol 58 Clolar ® 58 Aclidinium 58 CINTREDEKIN BESUDOTOX 58 dose cohorts 58 Romiplostim 58 Pafuramidine 58 severe hypercholesterolemia 58 Quinamed 58 Celacade TM technology 58 tramiprosate 58 hypoxia activated prodrug 58 opioid induced bowel dysfunction 58 LE SN# 58 Unit Dose Budesonide 58 MYDICAR 58 PGL# 58 RAPTIVA 58 TYGACIL 58 Adalimumab 58 zileuton CR 58 tasimelteon 58 Alfimeprase 58 dose escalation Phase 58 VPRIV 58 adalimumab Humira 58 Cellegesic 58 ridaforolimus 58 Phase III HEAT 58 cancer immunotherapies 58 humanized monoclonal antibody 58 PF # [001] 58 PANVAC VF 58 miconazole Lauriad ® 58 administered subcutaneously 58 Xcytrin R 58 Xerecept 58 IV Busulfex 58 Alocrest 58 ORENCIA R 58 Perforomist ™ Inhalation Solution 58 Poly ICLC 58 Roflumilast 58 hyperphenylalaninemia HPA due 58 Pegloticase 58 clofarabine 58 Orapred ODT 58 Blinatumomab 58 oncolytic virus therapies 58 LCP Tacro 58 ruboxistaurin 58 Clevudine 58 CCX# B 58 iloperidone 58 Sular formulation 58 Afatinib 58 rNAPc2 58 histamine dihydrochloride 58 arzoxifene 58 PROSTVAC ® 58 etanercept Enbrel 58 Glybera 58 alemtuzumab 58 Degarelix 58 relapsing MS 58 TOCOSOL Camptothecin 58 tyrosine kinase inhibitor 58 Argatroban 58 DAPT 58 pharmacokinetic PK study 58 ibudilast 58 pralatrexate 58 Veronate 58 alogliptin 58 Febuxostat 58 Gabapentin GR 58 NUVIGIL 58 Mepact 57 acyclovir Lauriad ® 57 secondary hyperparathyroidism 57 immunological diseases 57 DASISION 57 generation proteasome inhibitor 57 LibiGel ® 57 Sanvar R 57 LIALDA 57 BioMS 57 Exelixis compounds 57 Temsirolimus 57 HGS ETR2 57 immunotherapeutic 57 myelodysplastic syndrome MDS 57 HuMax TAC 57 Zolinza 57 Staccato loxapine 57 LCP AtorFen 57 Virulizin ® 57 TRV# [001] 57 DCCR 57 gemcitabine cisplatin 57 faropenem 57 THR beta agonist 57 Ixempra 57 BEMA Buprenorphine 57 Lovaxin C 57 RLY# 57 Otelixizumab 57 eprodisate Fibrillex TM 57 Panzem 57 vernakalant oral 57 Zingo TM 57 Numax 57 MEPACT 57 CTA# Injection 57 oral talactoferrin 57 ganetespib 57 zanolimumab 57 Desmoteplase 57 nucleotide analog 57 herpetic keratitis 57 relapsed refractory multiple myeloma 57 pegylated interferons 57 PSMA ADC 57 SUTENT 57 REPLAGAL 57 Neo Kidney Augment 57 ALN TTR 57 Darinaparsin 57 EGRIFTA TM 57 DPP4 inhibitor 57 Plenaxis R 57 aflibercept 57 IPX# 57 glufosfamide 57 crofelemer 57 Atrasentan 57 PNP inhibitor 57 superficial bladder cancer 57 Voreloxin 57 pancreatic insufficiency 57 Epanova 57 Tekamlo 57 Phase III psoriasis 57 Nanobodies 57 muraglitazar 57 JANUVIA 57 denufosol 57 Tracleer R 57 Heplisav 57 Stedivaze 57 SPP# [001] 57 Phase III Clinical Trial 57 Satraplatin 57 Phase 2a 57 PCK# 57 JAK2 inhibitor 57 ZADAXIN 57 candidate XP# 57 adipiplon 57 NPSP# 57 MAb 57 darapladib 57 Cand5 57 Nebido 57 rALLy trial 57 fidaxomicin 57 Debio 57 Benlysta belimumab 57 Dacogen 57 rhThrombin 57 Pemetrexed 57 sodium glucose transporter 57 sunitinib malate 57 sapacitabine 57 GW# [003] 57 gefitinib Iressa 57 ANYARA 57 IL# PE#QQR 57 PrevOnco 57 ADVEXIN 57 TG# [003] 57 SAR# [002] 57 DCVax R Brain 57 Tofacitinib 57 multi kinase inhibitor 57 Adnectin 57 goserelin 57 orally dosed 57 oral taxane 57 NEUMUNE 57 Fanapt TM 57 NOX E# 57 thalidomide Thalomid 57 mapatumumab 57 JAK inhibitors 57 REOLYSIN ® 57 pexiganan 57 Mozobil 57 CD3 monoclonal antibody 57 APTIVUS 57 cangrelor 57 recombinant factor VIIa 57 TLR9 agonist 57 preclinical efficacy 57 efalizumab 57 Tolamba 57 ATL# [002] 57 trastuzumab DM1 57 TRISENOX 57 PDX pralatrexate 57 ThermoDox R 57 inecalcitol 57 placebo controlled clinical 57 ALN VSP 57 Zoraxel 57 Iloperidone 57 BRILINTA 57 Aquinox 57 refractory angina 57 RoACTEMRA 57 Dermylex TM 57 DCVax R 57 Aptivus ® 57 investigational drug 57 TEMODAL 57 dexpramipexole 57 gabapentin enacarbil 57 EVIZON TM squalamine lactate 57 APTIVUS r 57 oral cladribine 57 BENLYSTA